• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

薏苡仁联合替莫唑胺治疗胶质母细胞瘤的疗效及机制的转录组学分析。

Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism.

机构信息

Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.

Neurosurgery, Linyi Traditional Chinese Medical Hospital, Linyi, 276000, Shandong, China.

出版信息

Sci Rep. 2023 Sep 19;13(1):15484. doi: 10.1038/s41598-023-41421-w.

DOI:10.1038/s41598-023-41421-w
PMID:37726303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10509239/
Abstract

The purpose of this study was to explore the role of coixendide (Coix) combine with temozolomide (TMZ) in the treatment of Glioblastoma (GBM) and explore its possible mechanism. CCK-8 was used to determine the inhibitory rate of Coix group, TMZ group and drug combination group on GBM cells, and the combination index (CI) was calculated to determine whether they had synergistic effect. Then RNA was extracted from each group, transcriptome sequencing was performed, and differentially expressed genes (DEGs) were identified. The possible mechanism was analyzed by GO enrichment analysis and KEGG enrichment analysis. The CI of Coix and TMZ indicating a synergistic effect when TMZ concentration is 0.1 mg/ml and Coix concentration is 2 mg/ml. Transcriptome sequencing analysis showed that interferon (IFN) related genes were down-regulated by Coix and up-regulated by TMZ and combined drugs, however, the up-regulation induced by combined drugs was less than that of TMZ. Besides IFN related genes, cholesterol metabolism pathway were also been regulated. Coix and TMZ have synergistic effects in the treatment of GBM at certain doses. RNA-Seq results suggested that the abnormal on genetic materials caused by DNA damage induced by TMZ treatment can be sensed by IFN related genes and activates antiviral IFN signaling, causing the activation of repairing mechanism and drug resistance. Coix inhibits IFN related genes, thereby inhibits drug resistance of TMZ. In addition, the activation of ferroptosis and the regulation of DEGs in cholesterol metabolism pathway were also contributed to the synergistic effects of Coix and TMZ.

摘要

本研究旨在探讨薏苡仁(Coix)联合替莫唑胺(TMZ)治疗胶质母细胞瘤(GBM)的作用及其可能的机制。采用 CCK-8 法检测 Coix 组、TMZ 组及药物联合组对 GBM 细胞的抑制率,计算联合指数(CI)判断是否具有协同作用。然后从各组提取 RNA,进行转录组测序,筛选差异表达基因(DEGs)。通过 GO 富集分析和 KEGG 富集分析对可能的作用机制进行分析。Coix 与 TMZ 的 CI 提示当 TMZ 浓度为 0.1mg/ml,Coix 浓度为 2mg/ml 时具有协同作用。转录组测序分析表明,Coix 下调 IFN 相关基因,TMZ 及联合药物上调 IFN 相关基因,但联合药物上调幅度小于 TMZ。除 IFN 相关基因外,胆固醇代谢途径也受到调控。在一定剂量下,Coix 和 TMZ 对 GBM 具有协同作用。RNA-Seq 结果提示,TMZ 治疗引起的 DNA 损伤所导致的遗传物质异常可被 IFN 相关基因感知,并激活抗病毒 IFN 信号,引起修复机制的激活和耐药。Coix 抑制 IFN 相关基因,从而抑制 TMZ 的耐药性。此外,铁死亡的激活和胆固醇代谢途径中 DEGs 的调控也有助于 Coix 和 TMZ 的协同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/fffd10355bf6/41598_2023_41421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/1d1163c6f862/41598_2023_41421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/d66257540dbf/41598_2023_41421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/f4f768e67213/41598_2023_41421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/f9b2aa261d58/41598_2023_41421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/a71f346e77a3/41598_2023_41421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/fffd10355bf6/41598_2023_41421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/1d1163c6f862/41598_2023_41421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/d66257540dbf/41598_2023_41421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/f4f768e67213/41598_2023_41421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/f9b2aa261d58/41598_2023_41421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/a71f346e77a3/41598_2023_41421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d527/10509239/fffd10355bf6/41598_2023_41421_Fig6_HTML.jpg

相似文献

1
Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism.薏苡仁联合替莫唑胺治疗胶质母细胞瘤的疗效及机制的转录组学分析。
Sci Rep. 2023 Sep 19;13(1):15484. doi: 10.1038/s41598-023-41421-w.
2
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.PDIA3P1 通过抑制 C/EBPβ 降解促进 Temozolomide 耐药,从而促进神经前体细胞向间充质转化。
J Exp Clin Cancer Res. 2022 Jul 15;41(1):223. doi: 10.1186/s13046-022-02431-0.
3
Establishment of a Novel Temozolomide Resistant Subline of Glioblastoma Multiforme Cells and Comparative Transcriptome Analysis With Parental Cells.建立新的替莫唑胺耐药胶质母细胞瘤细胞亚系及其与亲本细胞的比较转录组分析。
Anticancer Res. 2021 May;41(5):2333-2347. doi: 10.21873/anticanres.15008.
4
LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling.LINC00511 通过海绵吸附 miR-126-5p 和激活 Wnt/β-catenin 信号通路促进胶质母细胞瘤细胞对替莫唑胺的耐药性。
J Biochem Mol Toxicol. 2021 Sep;35(9):e22848. doi: 10.1002/jbt.22848. Epub 2021 Jul 30.
5
miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.miR-126-3p 通过靶向 SOX2 使胶质母细胞瘤细胞对替莫唑胺敏感,从而使 Wnt/β-catenin 信号失活。
Life Sci. 2019 Jun 1;226:98-106. doi: 10.1016/j.lfs.2019.04.023. Epub 2019 Apr 10.
6
Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.核因子 I A 通过激活核因子 κB 通路促进胶质母细胞瘤对替莫唑胺的耐药性。
Life Sci. 2019 Nov 1;236:116917. doi: 10.1016/j.lfs.2019.116917. Epub 2019 Oct 12.
7
miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.miR-140 通过靶向 CTSB 信号通路抑制胶质母细胞瘤的间充质转化并增强替莫唑胺的细胞毒性。
Pharmacol Res. 2019 Sep;147:104390. doi: 10.1016/j.phrs.2019.104390. Epub 2019 Aug 6.
8
Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells.替莫唑胺联合 AZD3463 治疗对胶质母细胞瘤细胞具有协同作用。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1497-1504. doi: 10.1016/j.bbrc.2020.10.058. Epub 2020 Oct 24.
9
Autophagy in combination therapy of temozolomide and IFN-γ in C6-induced glioblastoma: role of non-coding RNAs.自噬在替莫唑胺和 IFN-γ联合治疗 C6 诱导的脑胶质瘤中的作用:非编码 RNA 的作用。
Immunotherapy. 2023 Oct;15(14):1157-1169. doi: 10.2217/imt-2022-0212. Epub 2023 Aug 16.
10
Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.细胞外囊泡携带 miR-27a-3p 通过靶向 BTG2 促进胶质母细胞瘤对替莫唑胺的耐药性。
Cancer Chemother Pharmacol. 2022 Feb;89(2):217-229. doi: 10.1007/s00280-021-04392-1. Epub 2022 Jan 17.

本文引用的文献

1
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
2
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.阐明替莫唑胺耐药性在神经胶质瘤中的机制及克服耐药性的策略。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188616. doi: 10.1016/j.bbcan.2021.188616. Epub 2021 Aug 20.
3
[Expression and clinical significance of CXC chemokine ligand 10 in glioma].
CXC趋化因子配体10在胶质瘤中的表达及临床意义
Zhonghua Yi Xue Za Zhi. 2021 Apr 13;101(14):1031-1035. doi: 10.3760/cma.j.cn112137-20201020-02883.
4
CCAAT/Enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma.CCAAT/增强子结合蛋白δ介导胶质母细胞瘤中胶质瘤干细胞样细胞富集及ATP结合盒转运体ABCA1激活以产生替莫唑胺耐药性。
Cell Death Discov. 2021 Jan 12;7(1):8. doi: 10.1038/s41420-020-00399-4.
5
Effects of BMPER, CXCL10, and HOXA9 on Neovascularization During Early-Growth Stage of Primary High-Grade Glioma and Their Corresponding MRI Biomarkers.骨形态发生蛋白内皮相关因子、CXC趋化因子配体10及同源框A9在原发性高级别胶质瘤早期生长阶段对血管生成的影响及其相应的磁共振成像生物标志物
Front Oncol. 2020 May 5;10:711. doi: 10.3389/fonc.2020.00711. eCollection 2020.
6
A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.TAZ-ANGPTL4-NOX2 轴调控上皮性卵巢癌细胞铁死亡和化疗耐药。
Mol Cancer Res. 2020 Jan;18(1):79-90. doi: 10.1158/1541-7786.MCR-19-0691. Epub 2019 Oct 22.
7
Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis.薏苡仁油通过拮抗肌肉减少和脂肪脂解来改善癌性恶病质。
BMC Complement Altern Med. 2019 Oct 15;19(1):267. doi: 10.1186/s12906-019-2684-4.
8
Toward understanding the origin and evolution of cellular organisms.为了理解细胞生物的起源和进化。
Protein Sci. 2019 Nov;28(11):1947-1951. doi: 10.1002/pro.3715. Epub 2019 Sep 9.
9
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model.经重定向的溶瘤单纯疱疹病毒免疫病毒疗法根除神经胶质瘤的临床前模型研究。
Oncogene. 2019 Jun;38(23):4467-4479. doi: 10.1038/s41388-019-0737-2. Epub 2019 Feb 12.
10
LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.长链非编码 RNA-135528 通过 JAK/STAT 通路上调 CXCL10 抑制肿瘤进展。
Apoptosis. 2018 Dec;23(11-12):651-666. doi: 10.1007/s10495-018-1482-7.